preloader

Research achievements

text: 

Learn what BIG has already achieved in the field of breast cancer research. 

BIG against breast cancer is the philanthropic unit of Breast International Group (BIG). To review BIG’s research in greater depth, visit Breast International Group.

BIG’s
income invested in research
20 years
of hope & progress
10.000+
BREAST CANCER EXPERTS

BIG & 20 years of breast cancer research

 

A global network of academic research groups linking over 10,000 breast cancer experts.

 

20 years of hope & progress.

Philanthropic events

News highlights

20 years of research, 20km of Brussels


20-05-2019

Over one hundred participants ran for BIG against breast cancer! ..

Read more

BIG & 20 years of breast cancer research


04-02-2019

As BIG is celebrating its 20th anniversary this year, there’s no better time than now to spread our message of hope and progress...

Read more

A message from our Honorary President

Finding a cure is one of the biggest challenges faced by researchers from around the world. Breast cancer affects women and men of all ages. This is why prevention is crucial. When breast cancer is diagnosed, the impact on a patient’s life and loved ones is devastating and causes intense stress. Appropriate psychological and moral support is needed and can really make a big difference.

It is crucial to identify the most appropriate and personalised therapies to increase the chances of recovery and cure. BIG fosters collaboration among the world's leading experts in breast cancer and advances research. This is essential to give hope to everyone concerned.  - HRM the Queen of the Belgians, Honorary President

A message from our President

There are many areas of research that hold great promise for patients but have no particular interest for commercial partners.

That is why BIG develops and runs academic studies that hold tremendous potential for patients and promise long-term gains for society, in all regions of the world. Thanks to our global network of breast cancer experts, we can run these trials more efficiently.

- Martine Piccart, Co-founder and President

Our supporters